NRXP — NRx Pharmaceuticals Inc
In 2026 Q2, 3 of the 140 tracked hedge funds reported a position in NRx Pharmaceuticals Inc (NRXP), worth $402.98K combined. Over the quarter 3 opened or added, 0 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Quadrature | $178.34K | 0.00% | NEW |
| Renaissance | $157.87K | 0.00% | NEW |
| Persistent | $66.77K | 0.02% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.